AB-1005 Long-Term Follow-up Study

N/AEnrolling By InvitationNCT07081841

AskBio Inc132 enrolled

Overview

This is an observational, long term, follow-up study for participants with Parkinson's disease (PD) or Multiple System Atrophy-Parkinsonian subtype (MSA-P) who participated in prior interventional studies with AB-1005. It is intended to better understand the long-term safety of AB-1005, how well tolerated it is and how long lasting the effects are.

Study Type

OBSERVATIONAL

Enrollment

132

Conditions

Parkinson's Disease Multiple System Atrophy, Parkinson Variant

Interventions

ObservationOTHER

This is an observational study in which safety laboratories and non-invasive routine clinical assessments are conducted to gauge long term safety and efficacy.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * PD and MSA-P participants that are or were enrolled in an interventional AB-1005 study and provide informed consent Exclusion Criteria: * There are no exclusion criteria

Locations (2)

University of California San Francisco

San Francisco, California, United States

Ohio State University

Columbus, Ohio, United States

Outcomes

Primary Outcomes

Long term safety and tolerability

Measure of the occurrence of serious and non-serious adverse events

Time frame: Up to 10 years post surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.